SCHEMBL2494545

SCHEMBL2494545

[CH2]c1ccccc1-c1ccccc1CCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.35
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
LIPG Q9Y5X9 1/20 0.32
CTSL P07711 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
ELANE P08246 1/20 0.32
CTSG P08311 1/20 0.32
PDK2 Q15119 1/20 0.32
HTR1A P08908 1/20 0.32
DPP4 P27487 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
CSNK2A1 P68400 1/20 0.31
CSNK2A3 Q8NEV1 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492797 0.88 LIPG (0.42) PPARANR1H2NR1H3LIPGELANE
SCHEMBL6704515 0.87 PPARA (0.41) PPARANR1H2NR1H3LIPGCTSL
SCHEMBL2494391 0.85 ELANE (0.35) PPARANR1H2NR1H3ELANECTSG
SCHEMBL2493916 0.83 CSNK2A2 (0.43) PDK2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL135178 0.82 LIPG (0.36) PPARALIPGADRA2AADRA2BADRA2C
SCHEMBL3563199 0.75 PPARA (0.38) PPARANR1H2NR1H3LIPGCTSL
SCHEMBL4527020 0.75 KDM4E (0.38) PPARANR1H2NR1H3LIPGCTSL
SCHEMBL13685146 0.75 DPP4 (0.47) PPARADPP4ALDH1A1HPGD
SCHEMBL982272 0.75 HTR1A (0.47) PPARAELANECTSGHTR1ACYP2D6
SCHEMBL1646437 0.75 ALDH1A1 (0.54) PPARADPP4KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH PPARA 4095/4885NR1H2 3272/4885NR1H3 2833/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 PPARA 4009/4885NR1H2 3053/4885NR1H3 2569/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R PPARA 3843/4885NR1H2 2980/4885NR1H3 2510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.